Precision oncology: Ground zero
Dr. Gordon Mills is seeing outstanding early results in studies using cancer drugs in combination, like a one-two punch, to boost their effectiveness.
Dr. Gordon Mills is seeing outstanding early results in studies using cancer drugs in combination, like a one-two punch, to boost their effectiveness.
Meet three researchers at the OHSU Knight Cancer Institute — all united by the common goal of creating a world free from the burden of cancer.
On Sept. 7 and 8, OHSU’s Knight Cancer Institute opened the doors to its new Knight Cancer Research Building — an innovative building that will house up to 650 cancer researchers and staff focused on the early detection of cancer. We spoke with attendees on what they thought of the building.
OHSU Knight Cancer Institute opened the doors to its new Knight Cancer Research Building — an innovative building designed to transform how cancer research is done.
A Q&A with Bree Mitchell, PhD, who leads strategic planning, scientific program development, organizational development, operations, and scientific collaboration building as the Associate Director of the OHSU Knight Cancer Institute’s Cancer Early Detection Advanced Research Center (CEDAR).
One of the most highly cited medical scientists in the world, Gordon Mills, M.D., will be joining the faculty of the OHSU Knight Cancer Institute. He will hold the new Wayne and Julie Drinkward Chair in Precision Oncology. The Drinkwards, who established the chair with a gift of $2.5 million to OHSU, are longtime supporters […]